(by Daniel Stanciu, PhD)
During the past years, the field of re-purposed drugs, has gain an increasing traction in the oncology field. Drugs that are commonly used for various illnesses, are now proposed by scientist at major academic research centres across the world, as new approach to increase the effectiveness of conventional treatment. In some cases, the repurposed drugs can represent relevant alternatives to the conventional treatment approaches, or new treatment options for patients who have no other treatments available anymore.
By now, this is not theory anymore. It’s a fact. Indeed, many studies have demonstrated positive results in humans when the right re-purposed drugs are used in various cancers. Many of these studies, have been addressed in the website during the past years.
The major challenge of our society now is to find effective ways to translate this new knowledge to the medical system, in such a way so that the knowledge is adopted and implemented to improve and extend life of cancer patients. Therefore, we need to find ways to convey this new knowledge to clinicians such that they will not see it as ”alternative medicine” but as additional application of existing drugs. This is one major challenge of our society now.
Dr. Pavia Lumholt, may hold the answer to this challenge.
Dr. Lumholt, is a plastic surgeon in Denmark, with extensive experience in the public health care system. He often helped patients with breast reconstruction after breast cancer and microsurgical reconstruction, including large reconstructions after head & neck cancers and sarcomas.
While searching for ways to maximise the treatment outcome of his dear wife diagnosed some years ago as stage 4 breast cancer, Dr. Lumholt came across the value of repurposed drugs in oncology. Now, about 3 years post diagnostic Dr. Lumholt’s wife is in good health with no signs of cancer, after employing various treatments including chemo-, radio-therapy, food supplements and re-purposed drugs.
Dr. Lumholt, was kind enough to share with us here, his belief on what is the best and maybe the only way to implement knowledge on re-purposed drugs into the medical system, in a way that it will be adopted and applied by most of the general practitioners. And as you will see, that is not by calling them re-purposed drugs.
Please read the message of Dr. Lumholt shared below, and see his great TEDx talk following the link at the end of this post.
If you have the means to help and move this idea towards implementation, please let us know! If not, at least please share this post (via the share option at the end of the post) or the TEDx talk of Dr. Lumholt on your Facebook page in order to help reach as many people as possible and create awareness about this perspective. And hopefully one day, we can reach the momentum (people and money) required to implement the idea of Dr. Lumholt.
Do we want doctors to like alternative treatments, or do we prefer antagonism? Our words make all the difference
(by Dr. Pavia Lumholt, MD)
You see, most alternative cancer treatments are not…alternative. They are ordinary drugs, that have shown to interact positively with conventional cancer therapy like chemo, radiotherapy, immunotherapy and cancer surgery.
Taking drug interactions into account is a completely integrated part of medical decision making. Usually the focus is on negative interactions – potentially dangerous ones, that can cause harm when certain medications are taken together. But a good example of the opposite; deliberate simultaneous use of drugs, that enhance the effect of each other, is modern HIV treatment. Drug synergy is in fact the backbone of HIV treatment.
I am a strong believer in the value of drug synergy when it comes to cancer therapy. And I know, that one of the obstacles here is antagonism between the medical world and the alternative world.
But is doesn’t have to be like that.
Doctors like myself, will embrace beneficial drug interactions and use them rationally if we have the right tool. To begin with, such a tool will be used to adjust a cancer patient’s daily meds in favor of a better cancer outcome. But I have no doubt, that once the tool is there, doctors will engage in a more proactive off-label use of ordinary drugs with anticancer properties – repurposed drugs.
All it takes is for everyone to say the right words. Plus money of course to fund a beneficial drug effects tool. But the thing is; raising money is a whole lot easier than bringing two worlds together, that sometimes seem to enjoy antagonism.
The alternative world of cancer therapy is vast. And a lot of that will always be in opposition to established medicine.
But when it comes to beneficial drug interactions, there is no antagonism.
There is only one thing: Human intelligence.
Dr. Pavia Lumholt
E-mail: pavialu (at) gmail.com